Chlamydia pneumoniae infection of brain cells:: An in vitro study

被引:38
作者
Boelen, Ellen
Steinbusch, Harry W. M.
van der Ven, Andre J. A. M.
Grauls, Gert
Bruggeman, Cathrien A.
Stassen, Frank R. M.
机构
[1] Maastricht Univ, CARIM, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, EURON, European Grad Sch Neurosci, Dept Cellular Neurosci, NL-6200 MD Maastricht, Netherlands
[3] Radboud Univ Nijmegen Med Ctr, Dept Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
关键词
Chlamydia pneumoniae; brain cells; in vitro; mouse; infection; cell death;
D O I
10.1016/j.neurobiolaging.2006.02.014
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Inspired by the suggested associations between neurological diseases and infections, we determined the susceptibility of brain cells to Chlamydia pneumoniae (Cpn). Murine astrocyte (C8D1A), neuronal (NB41A3) and microglial (BV-2) cell lines were inoculated with Cpn. Infection was established by immunofluorescence and real-time PCR at various time points. Productive infection was assessed by transferring medium of infected cells to a detection layer. Finally, apoptosis and necrosis post-infection was detrmined. Our data demonstrate that the neuronal cell line is highly sensitive to Cpn, produces viable progeny and is prone to die after infection by necrosis. Cpn tropism was similar in an astrocyte cell line, apart from the higher production of extracellular Cpn and less pronounced necrosis. In contrast, the microglial cell line is highly resistant to Cpn as the immunohistochemical signs almost completely disappeared after 24 h. Nevertheless, significant Cpn DNA amounts could be detected, suggesting Cpn persistence. Low viable progeny and hardly any necrotic microglial cells were observed. Further research is warranted to determine whether these cell types show the same sensitivity to Cpn in an in vivo setting. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:524 / 532
页数:9
相关论文
共 43 条
[31]   USE OF HEP-2 CELLS FOR IMPROVED ISOLATION AND PASSAGE OF CHLAMYDIA-PNEUMONIAE [J].
ROBLIN, PM ;
DUMORNAY, W ;
HAMMERSCHLAG, MR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (08) :1968-1971
[32]  
SQUIRE LR, 2003, FUNDAMENTAL NEUROSCI, V2, P49
[33]  
Sriram S, 1999, ANN NEUROL, V46, P6, DOI 10.1002/1531-8249(199907)46:1<6::AID-ANA4>3.0.CO
[34]  
2-M
[35]   Association of Chlamydia pneumoniae with central nervous system disease [J].
Stratton, CW ;
Sriram, S .
MICROBES AND INFECTION, 2003, 5 (13) :1249-1253
[36]   Microglia as neuroprotective, immunocompetent cells of the CNS [J].
Streit, WJ .
GLIA, 2002, 40 (02) :133-139
[37]   Infectious agents and multiple sclerosis -: are Chlamydia pneumoniae and human herpes virus 6 involved? [J].
Swanborg, RH ;
Whittum-Hudson, JA ;
Hudson, AP .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 136 (1-2) :1-8
[38]   Failure to correlate C-pneumoniae with late onset Alzheimer's disease [J].
Taylor, GS ;
Vipond, IB ;
Paul, ID ;
Matthews, S ;
Wilcock, GK ;
Caul, EO .
NEUROLOGY, 2002, 59 (01) :142-143
[39]   Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae [J].
Tondella, MLC ;
Talkington, DF ;
Holloway, BP ;
Dowell, SF ;
Cowley, K ;
Soriano-Gabarro, M ;
Elkind, MS ;
Fields, BS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (02) :575-583
[40]   Respiratory infections and asthma: current treatment strategies [J].
Weinberger, M .
DRUG DISCOVERY TODAY, 2004, 9 (19) :831-837